HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 200...( - Q3 2008 Revenue of $49 millio...),Health
Navigation Links
HMS Holdings Corp. Announces Q3 2008 Results, 2008 Revised Guidance and Initial 2009 Guidance
Date:10/31/2008
- Q3 2008 Revenue of $49 million (+30%y/y), EPS $0.23 (+44% y/y)
- 2008 EPS Guidance Increased to $0.77 from $0.75 (+35% y/y)
- 2009 Initial EPS Guidance of $0.96
NEW YORK, Oct. 31 /PRNewswire-FirstCall/ -- HMS Holdings Corp. (Nasdaq: HMSY) today announced its financial results for the third quarter of 2008.
Third Quarter Results
For the quarter ended September 30, 2008 revenue increased 30% to $49.0 million, compared with $37.7 million for the same period a year ago. Net income for the quarter was $6.1 million (+48%) or $0.23 (+44%) per diluted share compared to net income of $4.1 million or $0.16 per diluted share for the same period a year ago.
For the nine months ended September 30, 2008, HMSY reported revenue of $132.1 million, an increase of $27.1 million or 26% from the $105.0 million for the same period a year ago. HMSY reported net income of $14.3 million (+31%) or $0.53 (+26%) per diluted common share for the nine months ended September 30, 2008, compared to net income of $10.9 million or $0.42 per diluted common share for the same period a year ago.
Guidance for 2008 and 2009
The company announced it has increased its 2008 guidance from $175.0 million in revenue, $50.0 million in adjusted EBITDA and $0.75 in fully diluted EPS to $181.0 million (+23% y/y) in revenue, $52.0 million (+28% y/y) in adjusted EBITDA and $0.77 (+35% y/y) in fully diluted EPS.
The company also announced its initial guidance for 2009. Revenue is projected to grow to $214 million (+18% over revised 2008 guidance). Adjusted EBITDA is expected to increase to $62.7 million (+21% over 2008 revised guidance), and fully diluted EPS is projected to increase to $0.96 (+25% over 2008 revised guidance).
"HMS has produced another record quarter, with strong revenue growth in
each of the government healthcare program markets that we serve," said
Robert Holster, Chairman and CEO. "With increasing une
'/>"/>
| SOURCE HMS Holdings Corp. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Fourth Quarter and Year End Earnings Webcast
2. XELR8 Holdings Announces Conference Call to Review Third Quarter Financial Results
3. China Pharma Holdings, Inc. to Initiate Clinical Trials For New Antibiotic Combination
4. HMS Holdings Corp. to Present at Oppenheimer 19th Annual Healthcare Conference
5. Lincare Holdings Inc. Announces Third Quarter and First Nine Months 2008 Financial Results
6. MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
7. Z Trim Holdings, Inc. Releases Letter to Shareholders
8. Z Trim Holdings, Inc. Announces Private Placement Funding
9. MBF Healthcare Acquisition Corp. Amends Stock Purchase Agreement With Critical Homecare Solutions Holdings, Inc. to Extend Termination Date to October 31, 2008
10. Zimmer Holdings to Present at Thomas Weisel Partners Conference
11. HMS Holdings Corp. to Present at Thomas Weisel Partners 2008 Healthcare Conference
Post Your Comments:
(Date:11/8/2009)...swire/ -- USAction this evening hailed passage of ...will make health care more affordable for consumer...se access to health care for millions of Americans...FDR and Harry Truman would be proud," said USActio...ks among our country,s proudest achievements. Toda...
(Date:11/8/2009)...th Working Families vs. Insurance Companies ,,...- On the heels of an historic late night vote in t...ealth care reform bill, the Pennsylvania AFL-CIO r...entatives voted on HR 3962, the Affordable Health ...h passed Saturday evening by a vote of 220 to 215,...
(Date:11/7/2009)...ire/ -- The American Medical Association (AMA) tod...nship and Community Service to Manus C. Kraff, M.D...recognizes physicians who have gone above and beyo...tanding public service contribution to their local...ing the opening session of the 2009 Interim Meetin...
(Date:11/7/2009)...swire/ -- With the final House vote on healthcare ...the entire bill hostage to further their antiabort...r beyond the status quo restrictions on abortion t... In an outrageous amendment, which is expected to ...emocrats are demanding explicit and unequivocal ex...
(Date:11/7/2009)...ciety of America (PRSA) will bestow the distinguis...vice president of Brand Strategy, Communications a... at PRSA,s 2009 International Conference in San Di... Fellows is one of the profession,s highest indivi...ow PRSA, and 2009 chair of the College of Fellows....
Breaking Medicine News(10 mins):Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3[0] History in the House: Quality, Affordable Health Care for America Is One Step Closer[0] Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge[0] AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members[0] Catholics for Choice Statement on Antiabortion Amendment to Healthcare Reform Bill[0] PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement
...ck adults to have their blood sugar, blood pressur...ven if they belong to a high-quality Medicare plan...published in Wednesday's Journal of the American M...ity in Providence, Rhode Island said, "This is not...
...ere Wednesday, taking the toll from mosquito-borne...ficials maintained that the number of cases had dr...anj in Uttar Pradesh, died at the All India Instit...were fluctuations in the platelet count," said D.K...
...timistic about personalized medicine enabled throu...the future.// Personalized medicine would not only...ease, ascertained by presence of the specific gene...ut will unravel the genetic blue prints for many c...
...mmunisation (JCVI) recommends vaccine for pregnant...eir unborn child// from the risk of leukemia.
...d get vaccinated in the second and third trimester...risk of morbidity and mortality in pregnant women,...
... acid every day could have better chance of gettin...d, a form of vitamin B is used in our bodies to ma...her body before she is pregnant, it can help preve... it helps conception too, reported online edition ...
... in children, The Medical Research Council has ale... with vivid colors, will do good// to reconsider, ...ad in paints.
Earlier in the year, the MRC ...as worrying is that, lead was found in paints mean...
Other Medicine News:Health News:Medicare Marked by Widespread Racial disparities 2Health News:13-Year-Old Boy Is Latest Dengue Victim; Delhi Toll 47 2Health News:Folic Acid Supplements Could Help Conception 2(Date:11/6/2009)... Watson Pharmaceuticals, ...ical company, announced today that Paul Bisaro, Wa... provide an overview and update of the Company,s b...e Conference on Wednesday, November 11, 2009 at 12...ion will be webcast live and can be accessed on Wa...
(Date:11/6/2009)...RNewswire-FirstCall/ -- Roper Industries, Inc. (...definitive agreement to acquire Verathon, Inc., a ...The Verathon Board of Directors has approved the t... regulatory approvals and closing conditions, incl...e closing to be completed in early December. ,...
(Date:11/6/2009)...swire-USNewswire/ -- America,s Specialty Medicines...d-market and smaller innovator pharmaceutical comp...he "Affordable Health Care for America Act," intro...ller companies fear that the cumulative effect of ...r efforts to bring new medicines to market. ,...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 1Covering Kids 26 Families with Health Insurance is Goal of Back to School Outreach Campaign 54850 2Foreclosures Plunge People Into Depression 54848 1Foreclosures Plunge People Into Depression 54848 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 1CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 3...--(BUSINESS WIRE)--Apr 30, 2007 - Insmed Inc.,(Na... Phase II,investigator-sponsored clinical study of...ents affected with HIV-associated,Adipose Redistri...the study, being conducted at the,University of Ca...of 0.5 mg/kg/day IPLEX treatment in seven patients...
..., done in collaboration with the Centro de,Investi...,University of Navarra, Pamplona, Spain, is being ...otterdam, the Netherlands. , AMSTERDAM, the Nether...tics BV (AMT), a leader in the field of human gene...ts AMT-020 gene therapy to,treat acute intermitten...
Other Medicine Technology:Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4Amsterdam Molecular Therapeutics BV to present preclinical,proof-of-concept data on its gene therapy AMT-020 to treat acute,intermittent porphyria 2Amsterdam Molecular Therapeutics BV to present preclinical,proof-of-concept data on its gene therapy AMT-020 to treat acute,intermittent porphyria 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |